Clinical Trials Logo

Opiate Withdrawal Syndrome clinical trials

View clinical trials related to Opiate Withdrawal Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05995535 Recruiting - Opioid Use Clinical Trials

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

UH3
Start date: January 1, 2024
Phase: Phase 2
Study type: Interventional

A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-NTX) are randomized 1:1 to lofexidine/pregabalin or lofexidine/pregabalin placebo for withdrawal management and offered XR-NTX if after completing withdrawal.

NCT ID: NCT05029401 Recruiting - Clinical trials for Opiate Withdrawal Syndrome

A Study of Oral Ibogaine in Opioid Withdrawal

Start date: April 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Study DMX-IB 201 is a Phase 1/2a study of ibogaine consisting of an initial single ascending dose escalation stage to determine the maximum tolerated dose (MTD) or treat-to-target dose (TTD) in healthy volunteers, followed by a randomized, double-blind, placebo-controlled proof of concept stage to demonstrate the efficacy, safety and tolerability of the selected dose in opioid-dependent patients who seek medically supervised opioid withdrawal